Skip to main content


Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss

Fig. 2

Differentiation and identification of human mesenchymal stem cells (hBMSCs). a Representative images demonstrate that primary hBMSCs were incubated and reached 90% confluence at day 7 while cells at passages 1 and 2 at day 3. Scale bar = 100 μm. b Flow cytometry was taken to measure the levels of the specific biomarkers CD73, CD14, CD44, CD45, CD106, CD105, CD29, CD11b, CD34, and Human Leukocyte Antigen-DR isotype (HLA-DR) in hBMSCs

Back to article page